Cost-utility model of brivaracetam in the adjunctive treatment of patients with epilepsy in Spain
Author:
Affiliation:
1. INECO, Universitat Politècnica De Valencia, Spain
2. Departamento De Organización De Empresas Y Marketing, Universidad De Vigo, Facultad De Ciencias Empresarias E Turismo, Ourense, Spain
Publisher
Informa UK Limited
Subject
Pharmacology (medical),Health Policy,General Medicine
Link
https://www.tandfonline.com/doi/pdf/10.1080/14737167.2021.1838899
Reference40 articles.
1. WHO | Epilepsy: aISBN public health imperative. ISBN 978-92-4-151593-1. World Health Organization. 2019. Printed in Thailand.
2. Incidence of epilepsy: A systematic review and meta-analysis
3. Challenges in epilepsy—The perspective of Norwegian epilepsy patients
4. Diagnosing and predicting refractory epilepsy
5. FEEN: Informe sociosantario FEEN sobre la epilepsia en España
Cited by 2 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Impact of Third-Generation Antiseizure Medications on People with Epilepsy in a Low-Income Population: The Brivaracetam Experience in a Real-World Study;Drugs - Real World Outcomes;2024-07-23
2. Determination of the economically justifiable price of cenobamate in the treatment of focal-onset seizures in adult patients with drug-resistant epilepsy in Spain;Expert Review of Pharmacoeconomics & Outcomes Research;2022-08-03
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3